Publication

Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Philippe Gautret, Aix Marseille UniversityKristina Angelo, Emory UniversityHilmir Asgeirsson, Karolinska University HospitalDavid G. Lalloo, Liverpool School of Tropical MedicineMarc Shaw, James Cook UniversityEli Schwartz, Sheba Medical CenterMichael Libman, McGill UniversityKevin C. Kain, University of TorontoWatcharapong Piyaphanee, Mahidol UniversityHolly Murphy, CIWEC Hospital and Travel Medicine CenterKarin Leder, Monash UniversityJean Vincelette, University of MontrealMogens Jensenius, Oslo University HospitalJesse Waggoner, Emory UniversityDaniel Leung, University of UtahSarah Borwein, TravelSafe Medical CentreLucille Blumberg, National Institute for Communicable DiseasesPatricia Schlagenhauf, University of ZurichElizabeth D. Barnett, Boston UniversityDavidson H. Hamer, Boston University
Language
  • English
Date
  • 2018-11-01
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • © 2018, Public Library of Science. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1935-2727
Volume
  • 12
Issue
  • 11
Start Page
  • e0006951
End Page
  • e0006951
Grant/Funding Information
  • GeoSentinel is supported by a cooperative agreement (U50CK00189) between the CDC and the International Society of Travel Medicine; funding was also received by GeoSentinel from the International Society of Travel Medicine and the Public Health Agency of Canada.
  • The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Abstract
  • Background: Recent studies demonstrate that rabies post-exposure prophylaxis (RPEP) in international travelers is suboptimal, with only 5–20% of travelers receiving rabies immune globulin (RIG) in the country of exposure when indicated. We hypothesized that travelers may not be receiving RIG appropriately, and practices may vary between countries. We aim to describe the characteristics of travelers who received RIG and/or RPEP during travel. Methodology/Principal findings: We conducted a multi-center review of international travelers exposed to potentially rabid animals, collecting information on RPEP administration. Travelers who started RPEP before (Group A) and at (Group B) presentation to a GeoSentinel clinic during September 2014–July 2017 were included. We included 920 travelers who started RPEP. About two-thirds of Group A travelers with an indication for rabies immunoglobulin (RIG) did not receive it. Travelers exposed in Indonesia were less likely to receive RIG in the country of exposure (relative risk: 0.30; 95% confidence interval: 0.12–0.73; P = 0.01). Travelers exposed in Thailand [Relative risk (RR) 1.38, 95% Confidence Interval (95% CI): 1.0–1.8; P = 0.02], Sri Lanka (RR 3.99, 95% CI: 3.99–11.9; P = 0.013), and the Philippines (RR 19.95, 95% CI: 2.5–157.2; P = 0.01), were more likely to receive RIG in the country of exposure. Conclusions/Significance: This analysis highlights gaps in early delivery of RIG to travelers and identifies specific countries where travelers may be more or less likely to receive RIG. More detailed country-level information helps inform risk education of international travelers regarding appropriate rabies prevention.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Parasitology

Tools

Relations

In Collection:

Items